BIOMAT Database Logo BIOMAT Database Logo

Pemphigus vulgaris induced by 5-aminolaevulinic acid-based photodynamic therapy. 2017

Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, PR China.

Pemphigus vulgaris (PV) is an autoimmune disorder resulting from the interaction between autoantibodies and desmoglein. Here, we report a case of PV developed after 5-aminolaevulinic acid-based photodynamic therapy (ALA-PDT). The harmful and deleterious effects of UV radiation on the onset, during course, and perpetuation of PV have been observed for decades. Correlation between reactive oxygen species (ROS) and PV have also been reported. Oxidative proteins, which are modified by ROS, and subsequent production of antibodies by immune system seem to be responsible for PV developed following ALA-PDT. We emphasize that ALA-PDT should be added to the list of possible factors triggering PV and this condition should be considered if blistering arises following ALA-PDT.

UI MeSH Term Description Entries
D007982 Levulinic Acids Keto acids that are derivatives of 4-oxopentanoic acids (levulinic acid). Acids, Levulinic
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
5-aminolaevulinic acid-based photodynamic therapy as a novel trigger of pemphigus foliaceus.
May 2022, Photodermatology, photoimmunology & photomedicine,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet B-induced skin photodamage.
January 2019, International journal of biological sciences,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy.
April 2004, Photodermatology, photoimmunology & photomedicine,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy.
January 2004, Journal of photochemistry and photobiology. B, Biology,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
January 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts.
January 2017, Medical science monitor : international medical journal of experimental and clinical research,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
[An experimental study on destruction of K562 and HL60 induced by 5-aminolaevulinic acid-based photodynamic therapy].
June 2005, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
October 2005, The Journal of dermatology,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy.
April 2017, Journal of medicinal chemistry,
Qian Zhou, and Peiru Wang, and Linglin Zhang, and Bo Wang, and Lei Shi, and Uma Keyal, and Anil Kumar Bhatta, and Guolong Zhang, and Xiuli Wang
Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy.
January 2004, The British journal of dermatology,
Copied contents to your clipboard!